Teva Pharmaceutical Industries Limited Forecasted to Earn Q2 2024 Earnings of $0.56 Per Share (NYSE:TEVA)

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Teva Pharmaceutical Industries in a research note issued to investors on Wednesday, May 29th. Zacks Research analyst R. Department now anticipates that the company will earn $0.56 per share for the quarter, down […]

Related Keywords

Israel ,United States ,America ,Piper Sandler ,Vikkil Conway ,Amir Weiss ,Securities Exchange Commission ,Zacks Research ,Covenant Trust Company ,Analysts At Zacks Research ,Jpmorgan Chase Co ,Goldman Sachs Group ,Teva Pharmaceutical Industries Price Performance ,Hr Department ,News Ratings For Teva Pharmaceutical Industries Daily ,Insider Activity At Teva Pharmaceutical Industries ,Blue Trust Inc ,Industrial Alliance Investment Management Inc ,Teva Pharmaceutical Industries Limited ,Teva Pharmaceutical Industries ,Entrypoint Capital ,Free Report ,Teva Pharmaceutical Industrie ,Pharmaceutical Industries ,Get Free Report ,Point Capital ,Alliance Investment Management ,Teva Pharmaceutical ,Exchange Commission ,Pharmaceutical Industries Limited ,North America ,Teva Pharmaceutical Industries Daily ,